Home › Funds › Ranmore Fund Management Ltd › REGN
Ranmore Fund Management Ltd position in REGN
REGENERON PHARMACEUTICALS · Health Care
Ranmore Fund Management Ltd reported holding 30,000 shares of REGN (REGENERON PHARMACEUTICALS) in its Q2 2026 13F filing — a position valued at US$18.7M, representing 2.07% of its reported portfolio and ranking #20 among its reported holdings. Ranmore Fund Management Ltd first reported this position in Q2 2026.
How Ranmore Fund Management Ltd's REGN position evolved
Ranmore Fund Management Ltd first disclosed a stake in REGN in Q2 2026 at 30,000 shares (US$18.7M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q2 2026 | 30.00K | $18.71M | New |
About REGN and 13F data
REGN (REGENERON PHARMACEUTICALS) is a Health Care company. 31 other funds we track also report a position in REGN — the largest reported positions include Vanguard Group (US$7.00B), BlackRock Inc (US$5.68B), VANGUARD CAPITAL MANAGEMENT LLC (US$4.13B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding REGN
- Vanguard Group 9.08M sh · $7.00B · Q4 2025
- BlackRock Inc 9.11M sh · $5.68B · Q2 2026
- VANGUARD CAPITAL MANAGEMENT LLC 6.63M sh · $4.13B · Q2 2026
- STATE STREET CORP 4.66M sh · $3.60B · Q1 2026
- Dodge & Cox 4.87M sh · $3.04B · Q2 2026
- DODGE & COX 4.87M sh · $3.04B · Q2 2026
- Invesco Ltd 3.94M sh · $2.46B · Q2 2026
- JPMorgan Chase & Co 3.77M sh · $2.38B · Q2 2026
- VANGUARD PORTFOLIO MANAGEMENT LLC 3.18M sh · $1.98B · Q2 2026
- Franklin Resources 2.77M sh · $1.73B · Q2 2026
- GEODE CAPITAL MANAGEMENT, LLC 2.63M sh · $1.63B · Q2 2026
- Geode Capital Management 2.63M sh · $1.63B · Q2 2026